Trupanion (NASDAQ:TRUP – Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of $0.1633 per share and revenue of $402.53 million for the quarter. Individuals can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 4:30 PM ET.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.05. The business had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. Trupanion had a return on equity of 5.96% and a net margin of 1.53%. The firm’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.22 earnings per share. On average, analysts expect Trupanion to post $0.63 EPS for the current fiscal year and $0.70 EPS for the next fiscal year.
Trupanion Trading Up 1.2%
Shares of NASDAQ:TRUP opened at $31.12 on Wednesday. The company has a market capitalization of $1.37 billion, a P/E ratio of 58.02, a P/E/G ratio of 1.84 and a beta of 1.27. Trupanion has a 1 year low of $21.16 and a 1 year high of $46.98. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The business’s 50 day simple moving average is $26.87 and its 200 day simple moving average is $26.65.
Insider Buying and Selling
In other Trupanion news, CFO Fawwad Qureshi sold 6,111 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total transaction of $183,391.11. Following the completion of the transaction, the chief financial officer directly owned 4,230 shares in the company, valued at $126,942.30. The trade was a 59.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO John R. Gallagher sold 3,604 shares of the company’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $29.70, for a total value of $107,038.80. Following the sale, the chief operating officer owned 33,742 shares of the company’s stock, valued at $1,002,137.40. The trade was a 9.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 14,046 shares of company stock worth $407,743. Corporate insiders own 5.58% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on the company. Stifel Nicolaus lifted their price objective on Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Weiss Ratings raised Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Cantor Fitzgerald reduced their target price on Trupanion from $34.00 to $30.00 and set a “neutral” rating on the stock in a report on Wednesday, October 7th. Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. Finally, Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat.com, Trupanion currently has an average rating of “Hold” and a consensus price target of $38.40.
Read Our Latest Analysis on TRUP
About Trupanion
Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.
The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.
Read More
- Five stocks we like better than Trupanion
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
